CARBINJECT contains Ferric Carboxymaltose Solution for Injection 50mg/ml in 2 ml & 10 ml vials. It should be administered via IV injection or infusion only. CARBINJECT is indicated as an iron replacement therapy used to treat iron deficiency anemia in children and adults with intolerance or inadequate clinical response to oral iron, and in adult patients who have non-dialysis & dialysis dependent chronic kidney disease.
CARBINJECT
COMPOSITION:
Ferric Carboxymaltose Injection 50 mg/ml
MODE OF ACTION:
Ferric carboxymaltose is a macromolecular ferric hydroxide carbohydrate complex, which allows for controlled delivery of iron within the cells of the reticuloendothelial system and subsequent delivery to the iron-binding proteins ferritin and transferrin, with minimal risk of release of large amounts of ionic iron in the serum. Intravenous administration of ferric carboxymaltose results in transient elevations in serum iron, serum ferritin and transferrin saturation, and, ultimately, in the correction of hemoglobin levels and replenishment of depleted iron stores.
INDICATIONS
CARBINJECT is indicated for the treatment of iron deficiency when oral iron preparations are ineffective or cannot be used and where there is a clinical need to deliver iron rapidly.
DOSAGE
Adults ≥50 kg:
750 mg IV every 7 days or more for 2 doses for a cumulative dose of 1,500 mg or 15 mg/kg/dose (Max: 1,000 mg/dose) IV as a single dose.
Adults <50 kg:
15 mg/kg/dose IV every 7 days or more for 2 doses. Treatment may be repeated if iron deficiency recurs.
Children and Adolescents:
15 mg/kg/dose (Max: 750 mg/dose) IV every 7 days or more for 2 doses.
STORAGE
Store at room temperature not exceeding 30ᵒC
DISCLAIMER
This information is for the medical professionals & registered medical practitioners only. This product must be consumed with the valid prescription of registered medical practitioners.*Images/Pack are for representation purpose only.